ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 924

B Cell Subsets and Dysfunction Of Regulatory B Cells In IgG4-Related Diseases and Primary Sjögren Syndrome: The Similarities and Differences

Wei Lin1, Lixia Jin2, Wen Zhang1, Hua Chen3, QingJun Wu4, Yunyun Fei1, Yan Zhao1, Xiaofeng Zeng5 and Fengchun Zhang3, 1Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China, 2Tsinghua University, Beijing, China, 3Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 4Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China, 5Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: B cells, IgG4 Related Disease, Sjogren's syndrome and regulatory cells

  • Tweet
  • Email
  • Print
Session Information

Title: B cells in Human and Animal Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: IgG4 related disease (IgG4-RD) is a chronic, multisystem-involved autoimmune disease. Abnormally activated and differentiated B cells may play important roles. Regulatory B cells (Breg) are newly defined B cell subgroups with immunosuppressive functions. In this study, we investigated the differences of B cell subsets, the expressions of co-stimulatory molecules on B cells, and the function of Breg cells in the peripheral blood of patients with IgG4-RD, primary Sjögren’s syndrome (pSS), and healthy donors. 

Methods: We recruited 38 newly diagnosed IgG4-RD patients, 38 newly diagnosed pSS patients and 30 healthy volunteers were included as disease and healthy controls. To analyze B cell subsets and B cell activity, PBMCs were surface stained with CD19, CD24, CD38, BAFF-R, CD40, CD80 and CD86 mAbs and then detected by flow cytometry. The function of Bregs was tested by co-culturing of isolated CD19+CD24hiCD38hi Breg cells with purified CD4+CD25- effector T cells.  Serum cytokines were measured by ELISA. Correlation of clinical data and laboratory findings were measured as well.

Results: Compared with pSS patients and healthy controls, IgG4-RD patients had a lower frequency of peripheral mature B cells and Breg cells. Interestingly, CD19+CD24-CD38hi B cell subsets were significantly higher in peripheral blood B cells from new-onset IgG4-RD patients than in pSS patients and healthy controls. The expression of BAFF-R and CD40 on B cells was significantly lower in IgG4-RD patients compared with those in pSS patients and healthy controls. Whereas, the expression of CD86 and CD80 on B cells was significantly increased in IgG4-RD patients compared with those in pSS patients and healthy controls. Unlike healthy B cells, CD19+CD24hiCD38hi Breg cells from pSS patients were lack of suppression function.

Conclusion: B cells in patients with IgG4-RD and pSS display a variety of abnormalities including disturbed B cell subpopulations, abnormal expression of key signaling molecules, co-stimulatory molecules. A significantly increased B cell subset, CD19+CD24-CD38hi B cells may play an important role in the pathogenesis of IgG4-RD.


Disclosure:

W. Lin,
None;

L. Jin,
None;

W. Zhang,
None;

H. Chen,
None;

Q. Wu,
None;

Y. Fei,
None;

Y. Zhao,
None;

X. Zeng,
None;

F. Zhang,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/b-cell-subsets-and-dysfunction-of-regulatory-b-cells-in-igg4-related-diseases-and-primary-sjogren-syndrome-the-similarities-and-differences/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology